Hmmm, yes you are right, just annoying, especially because LCT just doesn't get the press the company deserves.
Another solid week , Assen is on the money, Surely next week with the announcement that all has gone to plan and the final Group 3 Phase II patients treatments have been completed LCT will receive some well deserved media attention. I'd like to think that PR and Marketing would use this first milestone of completion to make some inroads into news agencies, gearing up for October/November when they announce to the world the first Medical Procedure to "Halt The Progression" of Parkinsons.
Hope all have a relaxing weekend ....
LCT Price at posting:
10.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)